Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan Cao

Showing results (541-550 of 590) with videos related to

Pageof 59
Sort By:
Medical Oncology (Northwood, London, England)|October 5, 2015
A phase I study of adjuvant intensity-modulated radiotherapy with concurrent paclitaxel and cisplatin for cervical cancer patients with high risk factorsPei Shu, Yali Shen, Yaqin Zhao, et al.
Medicine in Microecology|June 26, 2021
Analysis of the intestinal microbiota in COVID-19 patients and its correlation with the inflammatory factor IL-18Wanyin Tao, Guorong Zhang, Xiaofang Wang, et al.
Nature Communications|January 17, 2018
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancerTian Fang, Hongwei Lv, Guishuai Lv, et al.
International Journal of Biological Sciences|May 20, 2026
CRL4<sup>AMBRA1</sup>-mediated progesterone receptor degradation drives progestin resistance and represents a therapeutic vulnerability in endometrial cancerYaru Sheng, Ting Ni, Xiaoyi Ding, et al.
Acta Pharmacologica Sinica|May 4, 2022
Hepatocyte-derived VEGFA accelerates the progression of non-alcoholic fatty liver disease to hepatocellular carcinoma via activating hepatic stellate cellsHao Shen, Han Yu, Qian-Yu Li, et al.
Frontiers in Oncology|November 10, 2025
Validated nomograms for non-metastatic colorectal cancer prognosis prediction: a population-based studyYu-Dan Cao, Hong-Wei Sun, Tian-Ci Li, et al.
Molecular Cancer Therapeutics|June 28, 2013
Cyclin G1 expands liver tumor-initiating cells by Sox2 induction via Akt/mTOR signalingWen Wen, Tao Han, Cheng Chen, et al.
Frontiers in Oncology|June 25, 2024
Novel pretreatment nomograms based on pan-immune-inflammation value for predicting clinical outcome in patients with head and neck squamous cell carcinomaQian Chen, Shi-Yang Wang, Yue Chen, et al.
Nature Communications|January 21, 2021
The complex structure of GRL0617 and SARS-CoV-2 PLpro reveals a hot spot for antiviral drug discoveryZiyang Fu, Bin Huang, Jinle Tang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 7, 2016
Both de novo synthetized and exogenous fatty acids support the growth of hepatocellular carcinoma cellsDan Cao, Xinhua Song, Li Che, et al.
Pageof 59

Showing results (541-550 of 590) with videos related to

Sort By:
Pageof 59
Medical Oncology (Northwood, London, England)|October 5, 2015
A phase I study of adjuvant intensity-modulated radiotherapy with concurrent paclitaxel and cisplatin for cervical cancer patients with high risk factorsPei Shu, Yali Shen, Yaqin Zhao, et al.
Medicine in Microecology|June 26, 2021
Analysis of the intestinal microbiota in COVID-19 patients and its correlation with the inflammatory factor IL-18Wanyin Tao, Guorong Zhang, Xiaofang Wang, et al.
Nature Communications|January 17, 2018
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancerTian Fang, Hongwei Lv, Guishuai Lv, et al.
International Journal of Biological Sciences|May 20, 2026
CRL4<sup>AMBRA1</sup>-mediated progesterone receptor degradation drives progestin resistance and represents a therapeutic vulnerability in endometrial cancerYaru Sheng, Ting Ni, Xiaoyi Ding, et al.
Acta Pharmacologica Sinica|May 4, 2022
Hepatocyte-derived VEGFA accelerates the progression of non-alcoholic fatty liver disease to hepatocellular carcinoma via activating hepatic stellate cellsHao Shen, Han Yu, Qian-Yu Li, et al.
Frontiers in Oncology|November 10, 2025
Validated nomograms for non-metastatic colorectal cancer prognosis prediction: a population-based studyYu-Dan Cao, Hong-Wei Sun, Tian-Ci Li, et al.
Molecular Cancer Therapeutics|June 28, 2013
Cyclin G1 expands liver tumor-initiating cells by Sox2 induction via Akt/mTOR signalingWen Wen, Tao Han, Cheng Chen, et al.
Frontiers in Oncology|June 25, 2024
Novel pretreatment nomograms based on pan-immune-inflammation value for predicting clinical outcome in patients with head and neck squamous cell carcinomaQian Chen, Shi-Yang Wang, Yue Chen, et al.
Nature Communications|January 21, 2021
The complex structure of GRL0617 and SARS-CoV-2 PLpro reveals a hot spot for antiviral drug discoveryZiyang Fu, Bin Huang, Jinle Tang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 7, 2016
Both de novo synthetized and exogenous fatty acids support the growth of hepatocellular carcinoma cellsDan Cao, Xinhua Song, Li Che, et al.
Pageof 59